Janssen to Highlight Robust Solid Tumor Portfolio and Pipeline at 2021 ASCO GU
- Tuesday, February 2, 2021, 7:04
- Finance
- Add a comment
RARITAN, N.J., Feb. 2, 2021 /PRNewswire/ — The Janssen Pharmaceutical Companies of Johnson & Johnson announced today it will highlight the depth of its solid tumor portfolio at the American Society of Clinical Oncology Genitourinary (ASCO GU) Cancers Symposium with 12 data presentations,…
About the Author
adminasapcorp has written 39101 stories on this site.